menu search

ELV / Elevance Health: Beaten Down Share Price Offers Solid Potential

Elevance Health: Beaten Down Share Price Offers Solid Potential
Elevance Health's stock price has suffered due to uncertainties in the health industry and bond market, but the current price offers strong growth potential. The company's Carelon segment saw a 17.7% YoY increase in operating revenue, and its recent acquisition of Louisiana Health Service & Indemnity Company offers regional opportunities. Despite a drop in share price, ELV is considered a solid investment due to its dividend and cash flows, with the potential for a valuation of $552 per share in 2023, a 23% increase from the current price. Read More
Posted: Jul 10 2023, 04:57
Author Name: Seeking Alpha
Views: 101837

ELV News  

ELV vs. HQY: Which Stock Is the Better Value Option?

By Zacks Investment Research
October 27, 2023

ELV vs. HQY: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical Services sector might want to consider either Elevance Health (ELV) or HealthEquity (HQY). But which of th more_horizontal

Elevance Health: An Overlooked Healthcare Gem?

By Seeking Alpha
October 23, 2023

Elevance Health: An Overlooked Healthcare Gem?

With ELV's underlying markets growing at around 6-7% and the normalized FCF yield sitting at 6.8% at the moment, ELV should be able to deliver low dou more_horizontal

Is Elevance Health (ELV) a Solid Growth Stock? 3 Reasons to Think

By Zacks Investment Research
October 23, 2023

Is Elevance Health (ELV) a Solid Growth Stock? 3 Reasons to Think "Yes"

Elevance Health (ELV) could produce exceptional returns because of its solid growth attributes. more_horizontal

Elevance Health: Buy This Compounder For Growing Dividends

By Seeking Alpha
October 20, 2023

Elevance Health: Buy This Compounder For Growing Dividends

Elevance Health: Buy This Compounder For Growing Dividends more_horizontal

Elevance Health: A High Conviction Defensive Blue Chip Buy

By Seeking Alpha
October 19, 2023

Elevance Health: A High Conviction Defensive Blue Chip Buy

Elevance Health: A High Conviction Defensive Blue Chip Buy more_horizontal

Elevance Health (ELV) Beats Q3 Earnings, Hikes '23 Profit View

By Zacks Investment Research
October 18, 2023

Elevance Health (ELV) Beats Q3 Earnings, Hikes '23 Profit View

Elevance Health's (ELV) Q3 results gain on growing medical customer base and strong pharmacy product revenues. Adjusted net income is currently projec more_horizontal

Elevance Health (ELV) Q3 Earnings Top Estimates

By Zacks Investment Research
October 18, 2023

Elevance Health (ELV) Q3 Earnings Top Estimates

Elevance Health (ELV) came out with quarterly earnings of $8.99 per share, beating the Zacks Consensus Estimate of $8.45 per share. This compares to e more_horizontal

Elevance Health beats third-quarter profit estimates

By Reuters
October 18, 2023

Elevance Health beats third-quarter profit estimates

Elevance Health reported a better-than-expected third-quarter profit on Wednesday, helped by lower-than-expected medical costs for the health insuranc more_horizontal


Search within

Pages Search Results: